US Open Day 10 Preview: Four Must-See Matches - UBITENNIS
Connect with us


US Open Day 10 Preview: Four Must-See Matches



Roger Federer (

We are once again just one round away from Roger Federer and Rafael Nadal finally meeting at the US Open. Can they win their quarterfinal matches on Wednesday to make this New York tennis dream a reality? On the women’s side, we already have one all-American semifinal, with the potential to have all four semifinalists representing the US at the US Open.


Karolina Pliskova vs. CoCo Vandeweghe

Embed from Getty Images
After struggling in her second and third round matches, Pliskova embarrassed an overwhelmed young American opponent on Monday, losing just one game to Jennifer Brady. But Vandeweghe will not be overwhelmed by this occasion as Brady was. CoCo has embraced the Arthur Ashe Stadium crowd over the past week, heavily encouraging them to root her on. She’s already reached one major semifinal this year in Melbourne, and upset top seed Angelique Kerber during that run. She may be poised to eliminate another world number one on Wednesday. Vandeweghe and Pliskova are 2-2 lifetime, and they play similar styles, so there’s really not too much to separate them. Pliskova has struggled with the pressure of being number one, while Vandeweghe loves the big stage and the hometown crowd. Those may be the deciding factors in what should be a big-hitting quarterfinal.

Rafael Nadal vs. Andrey Rublev

Embed from Getty Images
The 19-year-old Rublev is the youngest US Open quarterfinalist since Andy Roddick in 2001. He has thoroughly impressed with two victories over top 10 seeds already in this tournament, ousting both Grigor Dimitrov and David Goffin. The future appears to be very bright for the young Russian, but it’s hard to imagine he’s ready to take out Rafael Nadal in the US Open quarterfinals. Nadal seems to have regained his mojo in easily dispatching of Alexandr Dolgopolov on Monday. Even if Rublev rises to this big occasion and starts off strong, Rafa should be able to grind the youngster down in the best-of-five format. Nadal is a solid favorite to return to the US Open semifinals for the first time in four years.

Madison Keys vs. Kaia Kanepi

Embed from Getty Images
Keys will again return to the night session schedule, where she’s used the support of the late night New York crowd to defeat Elena Vesnina and Elina Svitolina in her last two rounds. Her opponent on Wednesday evening is a shocking quarterfinalist considering what she’s recently been through. Kaia Kanepi is a five-time former major quarterfinalist, but has been through a tough few years since those glory days. The Estonian missed nearly two years of her career while suffering from Epstein-Barr virus as well as plantar fasciitis on both of her feet. Kanepi was ranked outside the top 400 when she arrived in New York. Kaia won three rounds of qualifying to earn her first main draw appearance in two years, and subsequently won four rounds in the main draw to make her sixth major quarterfinal. The bad news for Kanepi? She is 0-5 in five previous major quarterfinals. Kanepi had some luck go her way in the draw, as Keys will be the first seeded player she sees. Madison has the much bigger game and will be the heavy favorite to win here, but keep in mind the 22-year-old American can be extremely streaky. She suffered through some bad patches with many unforced errors in both of her previous rounds, only to recover in time to win in three sets. If Keys can handle the pressure of being the favorite, and continue to use the crowd to inspire her, she should get through to her second major semifinal.

Roger Federer vs. Juan Martin Del Potro

Embed from Getty Images
Wow, Del Potro’s effort to come back from two sets down against Dominic Thiem while severely hampered by a virus was magical. Will he have anything left against the 19-time major champion on Wednesday? It’s hard to believe playing a five-setter is the best road to recovery for Juan Martin. That being said, Federer’s health is also in question. After arriving in New York with a back injury, his movement has been much better in his last two matches, but he did take an injury timeout for some treatment during his fourth round match on Monday. Federer leads their head-to-head 16-5, with Roger winning their last three encounters. Del Potro has played spoiler before in dashing the hopes of those hoping for Federer to face Nadal in New York, when he defeated Nadal in the 2009 semifinals. He also went on to defeat Federer in the 2009 final to win his only major title. Let’s hope both men are feeling good and can raise this match close to the level of their last US Open encounter. And as hard as it is to root against Juan Martin, the tennis world will be keeping their fingers crossed for the much anticipated Roger/Rafa semifinal.


India’s Sumit Nagal Receives Sponsorship Boost After Revelling Financial Struggles



Image via

A leading food and drink company has pledged to support India’s highest-ranked men’s player who was unable to train at his usual facility in Germany earlier this year due to a lack of money. 


Earlier this week world No.159 Sumit Nagal made a public plea for financial support to help him continue his career as a tennis player. In recent years he has been based at the Nansel Tennis Academy in Germany but was unable to train there during the first three months of the 2023 season due to a lack of funds. During this period he relied on his friends, including former player Somdev Devvarman, to help maintain his fitness. 

“If I look at my bank balance, I have what I had at the beginning of the year. It is 900 euros. I did get a bit of help. Mr Prashant Sutar is helping me with MAHA Tennis Foundation and I also get monthly (salary) from IOCL but I don’t have any big sponsor,” Nagal told the Press Trust of India.
“I am investing whatever I am making. The yearly cost where I travel with one coach is costing me around Rs 8 million to Rs 10 million (90,000-113,000 euros) and that is just with one travelling coach (no physio). Whatever I have made I have already invested,” he added.

Nagal, who is 26 years old, has reached the semi-finals of better at five tournaments on the lower-level Challenger Tour so far this season. His only Grand Slam result was at the US Open where he lost in the first round of qualifying to Taro Daniel. It was at the US Open where he took a set off Roger Federer before losing in 2019. 

Despite being the only player from his country to be ranked in the top 400, Nagal is currently not part of the Target Olympics Podium Scheme. An initiative set up by the Indian government to provide support to their top athletes.

After learning about Nagal’s ongoing struggles on the Tour, a leading company has decided to support the tennis player by signing a three-year deal with him. Gatorade specializes in sports drinks and is manufactured by PepsiCo. Under the deal, Nagal will receive support with his recovery and nutrition from experts at the Gatorade Sports Science Institute (GSSI).  

“I am deeply moved and grateful to join hands with Gatorade. This association comes to me at a pivotal time, and I am thankful my hard work and passion is getting recognized and appreciated. With Gatorade by my side, I am sure I will reach new heights and give it my all both on and off the court,” the Indo-Asian News Service quoted Nagal as saying on Thursday. 

Speaking about the new partnership, Ankit Agarwal from PepsiCo India has hailed the collaboration. Agarwal is the company’s Associate Director of Energy & Hydration. 

“Sumit is a role model for the new-gen athletes of India with his career being a true example of hard work and sweat that makes talent shine,” he said.
“As a brand that is dedicated to supporting athletes in removing barriers to sporting success, we are delighted to welcome Sumit to the Gatorade squad.”

Nagal has been ranked as high as No.122 in the world. So far in his career, he has won four Challenger titles with two of those occurring this year in Italy and Finland. 

Continue Reading


(VIDEO): Malaga Line-Up Set As Davis Cup Most Unpredictable Tournament In History

UbiTennis founder Ubaldo Scanagatta explains why any of the eight teams in Malaga could win November’s Davis Cup Finals




(@DavisCup - Twitter)

The Davis Cup quarter-final line-up is set after an incredible Group Stage over Bologna, Split, Manchester and Valencia.


Now eight teams remain including Novak Djokovic’s Serbia, Great Britain and Australia.

However surprise teams such as the Netherlands, Finland and the Czech Republic will also appear in the quarter-finals.

Ten-time champions Great Britain will face Serbia with the winners taking on the winner of the quarter-final between Italy and the Netherlands.

In the other half of the draw Canada will be heavy favourites against Finland while the Czech Republic face Australia.

The final eight tournament will take place in Malaga and will take place between the 21st and the 26th of November.

However this year’s Davis Cup could be the most unpredictable version in the tournament’s history with there being no Spain or USA.

It really could be anyone’ tournament with Tennis’ most prestigious team competition up for grabs in November.

In this video UbiTennis founder Ubaldo Scanagatta explains why this year’s Davis Cup finals could be the most unpredictable edition of all-time and why any of the teams could win the title.

Continue Reading


Simona Halep Claims Doing Ban Is ‘Based On Scenarios’ Without Proof




Former world No.1 Simona Halep has questioned the fairness of her anti-doping hearing after being suspended from the sport for four years. 


The two-time Grand Slam champion is suspended from tour events until 2026 after an independent tribunal concluded that the Romanian broke rules set out in Tennis’ anti-doping program. In a 126-page report by the International Tennis Integrity Agency (ITIA), investigators accepted that the collagen supplement taken by Halep – called Keto MCT – was contaminated with Roxadustat “on the balance of probability.” However, they stated that there must have been another source of Roxadustat based on the level detected in her sample taken during the 2022 US Open. 

Furthermore, three experts in the area said they have ‘a high degree of confidence‘ that there was not an ‘innocent explanation’ for the abnormalities detected in Halep’s Athlete’s Biological Passport (ABP). They reported that ‘likely doping’ occurred based on an analysis of 51 valid samples of Halep’s blood and rejected her explanation for the irregularity. The tennis star cited blood loss during surgery and spells when she was inactive as her defence. 

Despite the comprehensive ruling, Halep has insisted that she is innocent and never intentionally took any banned substances. During an interview with Front Office Sports on Monday, the 31-year-old claimed that the ITIA’s four-year ban handed to her was based on ‘scenarios’ instead of any proof. 

“I was confident after the hearing because there were so many things that made no sense and that are not fair,” she said.
“When I received the decision, I was in complete shock. I could not believe that they suspended me for four years when we found the contamination and my blood was totally normal. They didn’t find anything bad in my blood. It’s crazy that they made this decision with everything [her legal team presented]. They judged me on scenarios. There is no proof. It’s just insane.”

The ITIA originally requested a six-year ban for Halep due to what they described as ‘repetitive and sophisticated’ doping practices. She is accused of using blood doping to improve her performance during Wimbledon and the US Open last year. However, the report found it was not ‘completely satisfied’ that Halep has been doping since March 2022 despite there being ‘strong grounds for suspicion.’

As for the substance Roxadustat, Halep says she would have never deliberately taken the drug as it would ‘work against her.’ She says that the drug would have worsened a thyroid issue which she has been dealing with for several years. Front Office Sports referred to a European Medicines Agency study which finds a possible link between the drug and decreased thyroid function. 

“There was no point for me to take this,” Halep said. “It’d work against me. It wouldn’t help me.”

The study couldn’t establish how common this side effect is due to the amount of data available at the time. 

In the wake of Halep’s ban, some have publicly expressed their views on the matter. One of the most notable to do so was Serena Williams who wrote on social media ‘8 is a better number” in a jibe at her former opponent. The reference was to the 2019 Wimbledon final when seven-time champion Williams lost in straight sets to Halep. 

“I think everyone has the right to judge me because the tribunal decided that I have the fault here,” Halep commented. “Someone told me today that those players who are hating on me because I beat them.”

Halep is set to appeal against her ban to the Court of Arbitration for Sport (CAS). 

Continue Reading